Anteilseigner
OrbiMed Advisors Private Equity (16,45 %) Ikarian Capital LLC (1,57 %) Two Sigma Investments LP (0,29 %) Two Sigma Advisers LP (0,28 %) Kestra Private Wealth Services LLC (0,23 %) Boothbay Fund Management LLC (0,19 %) Two Sigma Securities LLC (0,19 %) RhumbLine Advisers LP (0,14 %) Geode Capital Management LLC (0,09 %) G1 Execution Services LLC (0,08 %) Morgan Stanley Smith Barney LLC (Investment Management) (0,02 %) Moser Wealth Advisors LLC (0,00 %) Qube Research & Technologies Ltd. (0,00 %)
Kontakt
Chemomab Therapeutics Ltd.